Skip to main content

Table 1 Baseline characteristics

From: Mechanical effects of left ventricular midwall fibrosis in non-ischemic cardiomyopathy

  No MWF MWF P
N 84 32  
Age, yrs 62.3 ± 13.7 63.8 ± 11.9 0.29
Male, n (%) 51 (61) 27 (84) 0.02
Height, m 1.68 ± 0.09 1.74 ± 0.09 0.02
Weight, Kg 83.4 ± 18.6 83.3 ± 12.6 0.97
NYHA class    0.20
 I 4 (5) 3 (9)  
 II 15 (18) 8 (25)  
 III 47 (56) 11 (34)  
 IV 9 (11) 5 (16)  
 Unknown 9 (11) 5 (16)  
Diabetes mellitus, n (%) 13 (16) 7 (24) 0.42
Hypertension, n (%) 18 (22) 5 (17) 0.61
Atrial fibrillation, n (%) 15 (18) 8 (24) 0.44
Medication, n (%)    
 Loop diuretics 62 (81) 26 (89) 0.47
 ACE-I or ARB 77 (97) 27 (90) 0.31
 Beta-blockers 51 (65) 20 (66) 1.00
 Aldosterone antagonists 36 (46) 10 (35) 0.29
Systolic blood pressure, mmHg 124.3 ± 20.5 119.6 ± 23.1 0.38
Diastolic blood pressure, mmHg 71.5 ± 11.9 71.7 ± 13.8 0.96
QRS duration (ms) 144 (28) 149 (32) 0.48
  1. ACE-I angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blockers